Global Cardiovascular Catheters Market to Grow at a CAGR of 7.41% to 2021

MarketResearchNest.com adds “Global Cardiovascular Catheters Market 2017-2021” new report to its research database. The report spread across in 121 pages with table and figures in it.

Research analysts forecast the global cardiovascular catheters market to grow at a CAGR of 7.41% during the period 2017-2021.
Cardiovascular catheters are used in minimally invasive (MI) and non-invasive procedures. For the treatment of heart diseases, there is a growing need for cardiovascular catheters, which can be used for therapeutic and diagnostic purposes. The increasing number of AF cases and angiography cases grew the demand of such catheters in the market. The global cardiovascular catheters market presents significant growth opportunities to vendors in untapped markets, particularly in APAC. The market is highly dynamic and characterized by intense competition with the presence of many global and local players that develop safe, easy-to-use, cost-effective, and widely available products in the market. Also, it is a fragmented market owing to the presence of numerous vendors, which are focusing on one or more product segments.

Browse full table of contents and data tables at https://www.marketresearchnest.com/global-cardiovascular-catheters-market-2017-2021.html

Technavio recognizes the following companies as the key players in the global cardiovascular catheters market: Boston Scientific, St. Jude Medical, C. R. Bard, and Medtronic

Other Prominent Vendors in the market are:
Aachen Resonance, Abbott, ABIOMED, Acrostak, Advanced Cardiac Therapeutics, AdvanSource Biomaterials, Allium Medical Solutions, Alvimedica, AMG International, Andocor, Angioslide, Arstasis, Arthesys, ASAHI INTECC, Atrium, AV Medical, B. Braun Melsungen, Balton, Baylis Medical, Beijing Puyishengji Medical Technology, Biophan Technologies, Biosense Webster, BIOTRONIK, Blue Medical, BrosMed Medical, Cardiac Science, CardiacAssist, CardioFocus, Cardionovum, CathRx, Claret Medical, Contego Medical, Cook, CryoLife, Dextera Surgical, DVx, Edwards Lifesciences, ENDOCOR, ESSENTIAL MEDICAL, Eurocor, Galgo Medical, GaltNeedleTech, Hansen Medical, Innovative Cardiovascular Solutions, InSeal Medical, Intra special catheters, Japan Lifeline, JOTEC, KANEKA MEDIX, Keystone Heart, Lepu Medical, Medeon Biodesign, Medinol, Meril Life Sciences, Merit Medical Systems, MicroPort Scientific, Morris Innovative, Natec Medical, OptiMed, ORBUSNEICH, QT Vascular, Shockwave Medical, Smiths Medical, Spectranetics, STENTYS, Svelte Medical, Teleflex, Tokai Medical Products, Transluminal Technologies, Transverse Medical, US Endovascular, Vascular Closure Systems, Vasorum, and Vivasure Medical.

The latest trend gaining momentum in the market is Increase in M&A. Vendors undergo M&A to extend their product offerings, increase their market shares, and expand their operations. They acquire other companies to enhance their R&D capabilities for manufacturing innovative devices that meet consumer needs. The acquisition allows vendors to access the product portfolio of the acquired company.

Order a Premium Report Copy at https://www.marketresearchnest.com/purchase.php?reportid=255103

According to the report, one of the major drivers for this market is NHS health plans and EU insurance in UK. According to a study conducted by the Nuffield Department of Population Health, British Heart Foundation Centre on Population Approaches for Non-Communicable Disease Prevention, University of Oxford, UK in 2015, around 2.3 million people had CHD of which around 1.2 million people had a stroke, one million had AF, and 480,000 had heart failure. The EU provides European Health Insurance Card (EHIC), which provides access to the people to opt for healthcare provided by the state and country. If the procedure cost is less, then the card helps the patient to avail free of cost treatment.

Further, the report states that one of the major factors hindering the growth of this market is High cost of angioplasty products and procedures. PCI procedures such as stenting include angioplasty balloon catheters, a stent, and embolic protection devices. To insert the balloon catheter along with the stent, cardiologist widens the arteries. An embolic protection device is used to close the artery after the procedure is done. The estimated cost associated with stenting ranges between $12,000 and $38,000, which includes the cost of products and procedure. In such cases, the estimated cost of the stents will be around $2,000-$4,000, and the estimated cost of DEB in the US ranges between $8,500 and $11,000.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Inquiry before buying at https://www.marketresearchnest.com/enquirybuy.php?reportid=255103

MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.

Contact Us
Mr. Jeet Jain
Sales Manager
sales@marketresearchnest.com
+1-240-284-8070 / +44-20-3290-4151
Pune India

This release was published on openPR.